Defeat Duchenne Canada, the country's leading funder of Duchenne muscular dystrophy (DMD) research, is set to begin accepting innovative research proposals as of March 31, 2025. They are seeking ...
The death of a 16-year-old boy taking a gene therapy this month dealt a fresh blow to the Duchenne muscular dystrophy ...
Trial achieved key objectives for safety, tolerability, pharmacokinetics and pharmacodynamicsClinical data from this trial, together with ...
Whether a company operates in the dynamic beauty, sports nutrition, healthy aging, or better-for-you sectors of the nutritional supplement market, GELITA's versatile solutions are designed to ...
Werner held roles at Bristol Myers Squibb, AstraZeneca and Novartis before landing at Alltrna, where she works to develop tRNA-based treatments for a range of diseases.
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
About a dozen police cars, motorcycles and SWAT vehicles made their way down William's neighborhood with sirens and lights ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback